Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 182.00
-19.00 (-9.45%)
At close: Nov 10, 2025
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 32.01 billion as of November 12, 2025. Its market cap has decreased by -39.16% in one year.
Market Cap
32.01B
Enterprise Value
31.00B
Revenue
37.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
182.00
Market Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 32.01B, an increase of 645.25%. That is a compound annual growth rate of 21.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 31.50B | -25.39% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | 5.19B | 28.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 194.65B |
| PharmaEssentia | 164.97B |
| Bora Pharmaceuticals Co., LTD. | 75.59B |
| Lotus Pharmaceutical | 75.21B |
| Oneness Biotech | 29.08B |
| Pegavision | 26.48B |
| Center Laboratories | 26.24B |
| Lin BioScience | 23.91B |